HealthcareBiotech & Life SciencesFood & AgricultureClimate & EnergyMobility & TransportationConsumerConstruction
Obvious Ventures is a "world positive" venture capital firm that invests in early-stage companies solving humanity's biggest problems. Their strategy focuses on three core pillars: planetary health (sustainable systems), human health (healthy living), and economic health (people power), aiming for both significant financial returns and positive societal impact.
Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Average disclosed round size is $50.6M (across 66 rounds with reported amounts).
Portfolio
70
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
3
Team
JJ
James Joaquin
Co-Founder and Managing Director
VV
Vishal Vasishth
Co-Founder and Managing Director
RG
Rohan Ganesh
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
70 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Zanskar | Series C | $115M | Jan 2026 |
 Fleetzero | Series A | $43M | Jan 2026 |
 Obello | Seed | $8.5M | Nov 2025 |
| AAtaraxis AI | Series A | $20.4M | Mar 2025 |
 Baton | Series A | $10M | Jan 2025 |
 Pyka | Series B | $40M | Sep 2024 |
 LabGenius | Series B | $40.1M | May 2024 |
| Zanskar | Series B | $30M | May 2024 |
 Lightship | Series B | $34M | Jan 2024 |
 Arbor | Seed | $9M | Sep 2023 |
 Octave | Series C | $52M | Jun 2023 |
| IInato | Series A | $20M | Mar 2023 |
 Forum Mobility | Series A | $15M | Jan 2023 |
 Nectar | Series A | $16.5M | Dec 2022 |
 Plant Prefab | Series B | $42M | Dec 2022 |
 Brightside | Series B | $33M | Nov 2022 |
 SINAI Technologies | Series A | $22M | Sep 2022 |
 Incredible Health | Series B | $80M | Aug 2022 |
| SSynop | Seed | $10M | Jun 2022 |
 MycoMedica Life Sciences, PBC | Series C | $60M | Jun 2022 |
 Parallel Learning | Series A | $20M | May 2022 |
| PParallel | Series A | $20M | May 2022 |
| NNue Life Health | Series A | $23M | Apr 2022 |
 Lynx | Series A | $15M | Mar 2022 |
| CConcertoCare | Series B | $105M | Feb 2022 |
Page 1 of 3
Top Co-Investors
Andreessen Horowitz5 shared
Congruent Ventures4 shared
Lux Capital4 shared
Felicis Ventures4 shared
BoxGroup3 shared
Y Combinator3 shared
Giant Ventures3 shared
Prelude Ventures3 shared
Alumni Ventures Group3 shared
Two Sigma Ventures3 shared
Greycroft3 shared
Atomico3 shared
Inovia Capital3 shared
Innovation Endeavors3 shared
Stardust Equity2 shared
GV (Google Ventures)2 shared
Index Ventures2 shared
S2G Ventures2 shared
Founders Fund2 shared
Wireframe Ventures2 shared
Last updated: 13 March 2026